{"id":"https://openalex.org/W2019633596","doi":"https://doi.org/10.1016/j.drup.2011.01.003","title":"Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance","display_name":"Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance","publication_year":2011,"publication_date":"2011-02-17","ids":{"openalex":"https://openalex.org/W2019633596","doi":"https://doi.org/10.1016/j.drup.2011.01.003","mag":"2019633596","pmid":"https://pubmed.ncbi.nlm.nih.gov/21330184"},"language":"en","primary_location":{"id":"doi:10.1016/j.drup.2011.01.003","doi":"https://doi.org/10.1016/j.drup.2011.01.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drup.2011.01.003","pdf_url":null,"source":{"id":"https://openalex.org/S47159833","display_name":"Drug Resistance Updates","issn_l":"1368-7646","issn":["1368-7646","1532-2084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Resistance Updates","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2019633596"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018474663","display_name":"Alina Shapira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Alina Shapira","raw_affiliation_strings":["Russell Berrie Nanotechnology Institute, Technion, Haifa, Israel","Russell Berrie Nanotechnology Institute, Technion, Israel Institute of Technology, Haifa 32000, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russell Berrie Nanotechnology Institute, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]},{"raw_affiliation_string":"Russell Berrie Nanotechnology Institute, Technion, Israel Institute of Technology, Haifa 32000, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056084850","display_name":"Yoav D. Livney","orcid":"https://orcid.org/0000-0001-8273-9631","observed_orcids":["https://orcid.org/0000-0001-8273-9631"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Yoav D. Livney","raw_affiliation_strings":["Russell Berrie Nanotechnology Institute, Technion, Israel Institute of Technology, Haifa 32000, Israel","The Laboratory of Biopolymers and Food Nanotechnology, Department of Biotechnology & Food Engineering, Technion, Israel Institute of Technology, Haifa 32000, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russell Berrie Nanotechnology Institute, Technion, Israel Institute of Technology, Haifa 32000, Israel","institution_ids":["https://openalex.org/I174306211"]},{"raw_affiliation_string":"The Laboratory of Biopolymers and Food Nanotechnology, Department of Biotechnology & Food Engineering, Technion, Israel Institute of Technology, Haifa 32000, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109188456","display_name":"Henk J. Broxterman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Henk J. Broxterman","raw_affiliation_strings":["VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013852274","display_name":"Yehuda G. Assaraf","orcid":"https://orcid.org/0000-0001-6692-8221","observed_orcids":["https://orcid.org/0000-0001-6692-8221"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Yehuda G. Assaraf","raw_affiliation_strings":["The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel","institution_ids":["https://openalex.org/I174306211"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013852274","https://openalex.org/A5056084850"],"corresponding_institution_ids":["https://openalex.org/I174306211"],"apc_list":{"value":5410,"currency":"USD","value_usd":5410},"apc_paid":null,"fwci":2.4417,"has_fulltext":false,"cited_by_count":524,"citation_normalized_percentile":{"value":0.91506849,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"14","issue":"3","first_page":"150","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.05460000038146973,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.8270000219345093},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7940000295639038},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9660000205039978},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-efflux-pumps","display_name":"drug efflux pumps","score":0.8849999904632568},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.9200000166893005},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tumor-vasculature-targeting","display_name":"tumor vasculature targeting","score":0.8289999961853027},{"id":"https://openalex.org/keywords/chemosensitizers","display_name":"chemosensitizers","score":0.796999990940094},{"id":"https://openalex.org/keywords/combination-drug-delivery","display_name":"combination drug delivery","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.7015946507453918},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.5873974561691284},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.5795414447784424},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5758628845214844},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.5664879083633423},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5155689716339111},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.514805018901825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49224963784217834},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47573065757751465},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.46334466338157654},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4471288025379181},{"id":"https://openalex.org/C55427017","wikidata":"https://www.wikidata.org/wiki/Q1638475","display_name":"Cancer stem cell","level":3,"score":0.4313724637031555},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4270702600479126},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41415634751319885},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4128905236721039},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25337088108062744},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.20705294609069824},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.1889491081237793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10281369090080261},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.07015645503997803},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D057054","descriptor_name":"Molecular Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1016/j.drup.2011.01.003","doi":"https://doi.org/10.1016/j.drup.2011.01.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drup.2011.01.003","pdf_url":null,"source":{"id":"https://openalex.org/S47159833","display_name":"Drug Resistance Updates","issn_l":"1368-7646","issn":["1368-7646","1532-2084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Resistance Updates","raw_type":"journal-article"},{"id":"pmid:21330184","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21330184","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/995cb07d-ec44-4010-b778-88385e4c9a2e","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/995cb07d-ec44-4010-b778-88385e4c9a2e","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Shapira, A, Livney, Y D, Broxterman, H J & Assaraf, Y G 2011, 'Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance', Drug Resistance Updates, vol. 14, no. 3, pp. 150-163. https://doi.org/10.1016/j.drup.2011.01.003","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/37357","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/37357","pdf_url":null,"source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"14","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/d70f3836-9162-4b53-b346-1a2c568f8b5b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/d70f3836-9162-4b53-b346-1a2c568f8b5b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Shapira, A, Livney, Y D, Broxterman, H J & Assaraf, Y G 2011, 'Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance', Drug resistance updates, vol. 14, no. 3, pp. 150-163. https://doi.org/10.1016/j.drup.2011.01.003","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu2:oai:dare.ubvu.vu.nl:1871/37357","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1871/37357","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Resistance Updates, 14(3), 150","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/995cb07d-ec44-4010-b778-88385e4c9a2e","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/995cb07d-ec44-4010-b778-88385e4c9a2e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Resistance Updates, 14(3), 150 - 163. Churchill Livingstone","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":139,"referenced_works":["https://openalex.org/W161836838","https://openalex.org/W189719135","https://openalex.org/W272584808","https://openalex.org/W1510613202","https://openalex.org/W1545285984","https://openalex.org/W1548853485","https://openalex.org/W1696228719","https://openalex.org/W1830948261","https://openalex.org/W1966065114","https://openalex.org/W1967260930","https://openalex.org/W1968061953","https://openalex.org/W1968150155","https://openalex.org/W1972565370","https://openalex.org/W1978794594","https://openalex.org/W1982504977","https://openalex.org/W1983718760","https://openalex.org/W1992028431","https://openalex.org/W1992470182","https://openalex.org/W1993262772","https://openalex.org/W1993953120","https://openalex.org/W1994193939","https://openalex.org/W1994941022","https://openalex.org/W1996685148","https://openalex.org/W2000130246","https://openalex.org/W2000564895","https://openalex.org/W2001582257","https://openalex.org/W2007973519","https://openalex.org/W2008171455","https://openalex.org/W2008644875","https://openalex.org/W2012252658","https://openalex.org/W2013270956","https://openalex.org/W2014427634","https://openalex.org/W2014509855","https://openalex.org/W2015835531","https://openalex.org/W2016550154","https://openalex.org/W2018107585","https://openalex.org/W2019207861","https://openalex.org/W2019617397","https://openalex.org/W2019769726","https://openalex.org/W2023840934","https://openalex.org/W2024353213","https://openalex.org/W2028598028","https://openalex.org/W2032903792","https://openalex.org/W2034791477","https://openalex.org/W2035045849","https://openalex.org/W2036551119","https://openalex.org/W2036561049","https://openalex.org/W2036671354","https://openalex.org/W2037303548","https://openalex.org/W2038713860","https://openalex.org/W2038735819","https://openalex.org/W2038974631","https://openalex.org/W2044090247","https://openalex.org/W2044133019","https://openalex.org/W2044154925","https://openalex.org/W2048912984","https://openalex.org/W2049264404","https://openalex.org/W2053923285","https://openalex.org/W2054603000","https://openalex.org/W2055904567","https://openalex.org/W2056201229","https://openalex.org/W2056842925","https://openalex.org/W2060459188","https://openalex.org/W2063552635","https://openalex.org/W2063764833","https://openalex.org/W2064674946","https://openalex.org/W2065079114","https://openalex.org/W2067345730","https://openalex.org/W2067848116","https://openalex.org/W2067882963","https://openalex.org/W2069651638","https://openalex.org/W2069876014","https://openalex.org/W2073045696","https://openalex.org/W2074688366","https://openalex.org/W2075160397","https://openalex.org/W2078771990","https://openalex.org/W2078810029","https://openalex.org/W2082897515","https://openalex.org/W2083870878","https://openalex.org/W2087266891","https://openalex.org/W2088210361","https://openalex.org/W2090450679","https://openalex.org/W2093758237","https://openalex.org/W2095220493","https://openalex.org/W2099526972","https://openalex.org/W2101673712","https://openalex.org/W2102449174","https://openalex.org/W2103056710","https://openalex.org/W2103082495","https://openalex.org/W2103262726","https://openalex.org/W2106483532","https://openalex.org/W2108527751","https://openalex.org/W2108549696","https://openalex.org/W2108882170","https://openalex.org/W2110377632","https://openalex.org/W2111030305","https://openalex.org/W2111441190","https://openalex.org/W2112430792","https://openalex.org/W2113689159","https://openalex.org/W2115298175","https://openalex.org/W2115401462","https://openalex.org/W2115611402","https://openalex.org/W2118278569","https://openalex.org/W2118411153","https://openalex.org/W2118480909","https://openalex.org/W2120295527","https://openalex.org/W2123799923","https://openalex.org/W2126107019","https://openalex.org/W2132009661","https://openalex.org/W2137228719","https://openalex.org/W2137768930","https://openalex.org/W2137984061","https://openalex.org/W2138124227","https://openalex.org/W2139959086","https://openalex.org/W2146317534","https://openalex.org/W2148726864","https://openalex.org/W2149888039","https://openalex.org/W2150702593","https://openalex.org/W2152175544","https://openalex.org/W2154992334","https://openalex.org/W2155248907","https://openalex.org/W2155520720","https://openalex.org/W2157263222","https://openalex.org/W2159567970","https://openalex.org/W2159672669","https://openalex.org/W2164121748","https://openalex.org/W2165004581","https://openalex.org/W2168236445","https://openalex.org/W2169752086","https://openalex.org/W2331790104","https://openalex.org/W2415636075","https://openalex.org/W2897986424","https://openalex.org/W4233976617","https://openalex.org/W6632377654","https://openalex.org/W6680448445","https://openalex.org/W6716065139","https://openalex.org/W6717229836","https://openalex.org/W7073938519","https://openalex.org/W7074219273"],"related_works":["https://openalex.org/W2559764050","https://openalex.org/W4289343308","https://openalex.org/W3192447201","https://openalex.org/W2126107019","https://openalex.org/W2614719195","https://openalex.org/W4381248948","https://openalex.org/W6968255841","https://openalex.org/W2016046859","https://openalex.org/W3000448813"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":31},{"year":2022,"cited_by_count":31},{"year":2021,"cited_by_count":29},{"year":2020,"cited_by_count":35},{"year":2019,"cited_by_count":33},{"year":2018,"cited_by_count":31},{"year":2017,"cited_by_count":28},{"year":2016,"cited_by_count":53},{"year":2015,"cited_by_count":52},{"year":2014,"cited_by_count":51},{"year":2013,"cited_by_count":45},{"year":2012,"cited_by_count":33}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
